RA
Ramadevi Amaram
About Ramadevi Amaram
Data last updated:
Ramadevi Amaram is a Director at Eswar Bio Briquette India Private Limited (since 2015) and Director at Rx-Infinity Therapeutics Private Limited (since 2023). The companies operate in Metals and Minerals, Paper and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹5.79 Cr; the largest is Eswar Bio Briquette India Private Limited at ₹5.59 Cr (FY 2024). Earlier, Ramadevi Amaram was a Director at Relez Pharma Private Limited (2021–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Eswar Bio Briquette India Private Limited U37100TG2012PTC083172 | Director | 04 Nov 2015 | 2012 | ₹5.59 Cr (FY 2024) | Active |
| Rx-Infinity Therapeutics Private Limited U21001TS2023PTC173621 | Director | 31 May 2023 | 2023 | ₹19.5 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Relez Pharma Private Limited U24290GJ2021PTC121177 | Director | 15 Mar 2021 | 2021 | ₹1.44 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ramadevi Amaram
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajani Yarlagadda | 06372508 | Eswar Bio Briquette India Private Limited | Director |
| Sreekanth Nagith Kumar Kolla | 06373621 | Eswar Bio Briquette India Private Limited | Managing Director |
| Manikanth Reddy Yarala | 08238920 | Rx-Infinity Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramadevi Amaram
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramadevi Amaram
Ramadevi Amaram currently holds 2 directorships: Eswar Bio Briquette India Private Limited (Director, since 04 Nov 2015, revenue ₹5.59 Cr (FY 2024)); Rx-Infinity Therapeutics Private Limited (Director, since 31 May 2023, revenue ₹19.5 Lakh (FY 2025)).
Ramadevi Amaram was first appointed on 04 Nov 2015 as Director at Eswar Bio Briquette India Private Limited. The most recent appointment on record is 31 May 2023 at Rx-Infinity Therapeutics Private Limited.
The 2 current companies of Ramadevi Amaram that report revenue have a combined latest revenue of ₹5.79 Cr: Eswar Bio Briquette India Private Limited ₹5.59 Cr (FY 2024); Rx-Infinity Therapeutics Private Limited ₹19.5 Lakh (FY 2025).
Ramadevi Amaram held 1 earlier board appointment: Relez Pharma Private Limited (Director, 15 Mar 2021 to 25 May 2023).
The current boards of Ramadevi Amaram's companies include Rajani Yarlagadda (Eswar Bio Briquette India Private Limited), Sreekanth Nagith Kumar Kolla (Eswar Bio Briquette India Private Limited), Manikanth Reddy Yarala (Rx-Infinity Therapeutics Private Limited).